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formed by standard methods and API systems (bioMerieux). The suscept-
ibility testing was carried out by disc diffusion method.
Results: Peritonitis developed 13 patients (65%) in overall 23 episodes.
Peritonitis rate was I episode per 11.3 patient-month. From the patients 4{13
had three episodes, 2{13 two, and 7{13 one. In 6{23 of the peritonitis cases
were polymicrobial. The most frequent isolated bacteria were CNS (17.9%)
and Pseudornonas spp (17.9%), followed by Staphylocoaus aureus (10.7%),
Kiebsiella spp (10.7%), Acinetobaeter johnsonii (7.1"!o) and Streptococcus spp
(7.1 %). Fungi were isolated in 10.7%. It is worthnoting the isolation ofvery
rarely reported microbial species, as Ledercia adecarboxylata, Ewingella amer-
icana, Wangiella dermatitidis and Cryptococcus humicolus.
Condusions: Peritonitis was frequent in CAPD population studied. The
most frequent causative agents were CNS and Pseudomonas spp. Very rarely
causative agents were also isolated.
IWeP324I Bacteremia and fungaemla in pediatric versus adult
cancer patients after chemotherapy: Comparison of etiology,
risk factors and outcome
M. Kiskova\ I. Krupova3•5, E. Kaiscroval , A. Foltinoval , G. Kovacicova4,
A. Krchnakova3, K. Lajchova4, K. Stopkova4, A. Kunova2,J. Trupe, S.
Spanik2, D. West6
tNational Pediatric Ca,ller Cetlter Children's Hospital Bratislava; 2National
Canter Institute, Dept. ofMedicine, Dept. ofMicrobiology, Bratislava; 3St.
Elizabeth Cancer Institute, Dept. of Pharmacology, Bratislava; 4 University of
Tmava, School ofPublic Health, Trnava; sPostgrad Med School, Dept. of
Chemotherapy, Bratislava, Slovakia; 6University of Scranton, Dept. ofHealth
Managemetlt, Scranton, PA, United States
Objectives: One hundred and eighteen (118) episodes of bacteremia and
fungaemia in children with cancer and bacteremia we compared to 401
episodes of bacteremia and fungaemia in adults with cancer to asses
differences in etiology, risk factors and outcome.
Methods: Retrospective univariety analysis of all episodes of bacteremia in
National pediatric and National adult cancer Institutions, appearing in
1990-1996 was performed. Together 519 episodes of bacteremia, 118 in
children and 401 adults were assessed and compared. Both centers differed in
prophylactic antibiotics policies. About 50% of adults but less than 5% of
children received quinolone prophylaxis during neutropenia, however
empiric antibiotic therapeutic strategy was similar.
Results: There were differences in etiology between both groups: staphy-
lococci and S. maltophilia were more frequently observed in children (p <
0.01), Ps. aeruginosa and Acinetobacter spp. in adults (p < 0.05). Grampo-
sitive bacteremia was surprisingly more commonly observed in adults (65.7
vs 33.3, P < 0.01). Mixed polymicrobial bacteremia occured more com-
monly in adults (31.8% vs 7.6%, P < 0.001) than in children. Analysis ofrisk
factors did not observed differences in risk factors except of underlying
disease (acute leukemia was more frequently observed in children - 48.3% vs
adults 33.7, p < 0.05 and prophylaxis: (prior prophylaxis with quinolones
was commoner in adults (47.5%) than in children (2.5%) p < 0.0001).
Overall and attributable mortality in pediatric bacteremia was significantly
lower than in adults (p < 0.03).
Condusions: Pediatric cancer patients showed different etiology of bacter-
emia than adults. perhaps due to different prophylactic strategies. Despite the
majority of children did not receive any prophylaxis, overall and attribu-
table mortality of bacteremia was lower in comparison to adult cancer
patients.
[weP325] Fungal colonisation and susceptibility to
antimycotic agents of fungi Isolated from children with bone
marrow transplantation
U. Nawrot1, K.Juszczak2, M. Bartoszewicz-Potyrala1, B. Gusin t
'Departmetlt ofMicrobiology Medical University of Wrodaw, Poland;
2Department ofChildren Hematology and Oncology University Hospital
Objectives: The aim of this study was to determine fungal colonisation{
infections in oral cavity, pharynx, gastrointestinal tract, genitourinary
system of transplant children and evaluate the susceptibility of cultured
fungi to amphotericin B, 5-f1uorocytosine, miconazole, ketoconazole,
fluconazole, itraconazole.
Methods: Since October 1998 in 40 hematological patients (21 with auto-
logical and 19 allogenical transplantation) quantitative and qualitative
mycological investigation< were cnried out. Fungi were identified by
morphological (chlamydospores, filamentation test) and biochemical data
(1D32C, BioMcrieux). The susceptibility testing was performed usmg
breakpoint, broth rnicrodilution technique (Fungitest, Sanofi Diagnostics
Pasteur). .
Results: Fungi were found in 1-5 clinical specimens of one patients, most
frequent in faces (50 strains), pharyngeal swabs (30 strains) and urine (6), only
one C. guillermondi were cultured from blood. 105 fungal strains were found,
among them 74 (70%) C. albieans, 6C.glabrata, 5 C. krusei, 15 Candidaspp., 2
R. rubra, 1 G. candidum, 1 S. eerevisiae and 1 C. albidus. The most effective "in
vitro" antifungal agents were amphotericin B (only G. candidum moderately
sensitive) and 5-f1uorocytosine (8 non-C. albicans strains moderately sensi-
tive). Candida strains showed difference in susceptibility to azoles. 48 (64%)
C. a/bicans strains were susceptible to all tested azoles, 16 (21.6%) were
moderately sensitive and 10 (13.5%) were resistant to 1-3 azoles. Among 26
non-C. albicans strains 8 were resistant and 18 moderately sensitive to 1-4
azolcs
Conduslons: Patients undergoing bone marrow transplantation are fre-
quently colonised with fungi, that may be resistant to commonly used
antifungal drugs. Mycological investigations in this patients can be system-
atically performed.
IWeP326I Polyomavirus BKY DNA In plasma Identifies renal
allograft recipients with BK nephropathy
H. H. Hirsch, V. Nickeleit, M. Mihatsch, I. Binet, T. Klimkait, G. Thiel.
P. Dalquen
University Hospitals Basel, Switzerland
Background: Reactivation of BKV is increasingly recognised as a cause of
renal allograft dysfunction and loss. Currently patients (pts) at risk for BKV
nephropathy (BKN) are identified by BKV-inclusion cells, so-called "decoy
cells", in urine, a test oflow specificity, or allograft biopsy which is invasive.
Methods: In a retrospective analysis, we performed PCR for BKV on
plasma from 9 renal allograft pts with BKN, 41 other renal allograft pts (16{
41 shedding "decoy cells") and 17 AIDS pts (CDC stage C3) as immuno-
compromised controls.
Results: BKV DNA was detected in the plasma of9{9 patients with BKN at
the time of the initial histological diagnosis 46 ± 28 weeks post-transpIanta-
tion and during histologically persisting BKN. In 3{6 pts studied serially after
transplantation, BKV DNA was initially undetectable, but was detected 16-
33 weeks before BKN was confirmed by biopsy. BKV DNA became
negative in plasma with resolution of BKN when the immunosuppressive
regimens were decreased in 2 pts. and after removal ofthe renal allograft in 3
pts. DRV DNA was found in plasma of only 2/4\ renal allograft pts wlo
BKN and 0{17 AIDS pts.
Condusions: BKV PCR on plasma is sensitive (100%) and specific (95%)
for BKN. We propose a diagnostic algorithm ofi. urine cytology, ii. plasma
PCR iii. graft biopsy iv. plasma PCR for monitoring the effects ofreducing
immunosuppression.
P:16/2 - Infections in the immunocompromised host -II
--IWeP327I Presence of unique motile cells In lower~ory
tract infections and body fluid of immuno compromised '" .
patients. (A microbiologists dilemma) "
S. Nagarajan. S. K. Jain, Amn Dewan, S. S. Arora
Dept. Laboratory Medicine, Batra Hospital & Medical Research Centre, New
Delhi, India
The presence ofunusual protozoa-like structure in the bronchial aspirates of
immuno compromised patients were noticed. The unique feature was three
types of motility oscillating, cilliary and amoeboid were seen simulta-
neously. These cells were viable in vitro for a period of three days to five
days. The size ofthe trophozoites is 35-40 microns, with tufts ofcillia. at one
end of the cells 45-50 in number, length is 28-30 microns. 60% of the
patients in whom these were seen had fatal outcome. Three years study on
various aspects of these abnormal cells will be presented by the author. The
controversy of its being a cilliated respiratory cell will be presented. It is a
microbiologists dilemma as it is extremely difficult to recover in culture. In
about 4 patients cysts could be demonstrated in NNA medium. Presence of
dislodged respiratory cells can be seen in CSF. We have also seen those
protozoa like cells in body fluids.
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IWeP328! Monitoring of functional state of neutrophils and
nitric oxide and cardiosurgery infectious complications
E. N. Bachinskayal , N. V. Beloborodova2, A. N. Osipov l
lMoscow State University; 2Academician Isakov Scientific Group, Moscow,
Russian Federation
Objectives: The infectious complications are one of the most difficult
problems in the cardiosurgery. We prospectively investigated the dynamics
of neutrophils respiratory burst and nitric oxide (NO) production from
cardiosurgery patients before and after operation.
Methods: Ten patients with acquired heart diseases were studied before
cardiosurgical operation, directly after, 48 hours and 7 days after operation.
Luminol-enhanced chemiluminescent (CL) response of whole blood stimu-
lated with electric impulse, dynamics of leukocytes number and NO
production were measured. Five donors were examined as a control group.
Results: We received two groups (A and B) of patients CL response. The
group A (n = 3) had increase ofCL directly after operation and at 48 h after
operation compared to data before (p < 0.01) and at7 day after operation (p
< 0.05), that correspond the dynamics ofleukocytes number. In this group
postoperative infectious complications were marked in two cases. In the
group B (n = 3) CL was not changed significantly at this time, postoperative
infectious complications didn't develop. We got two groups (C and D) of
patients by NO production. In the group C in = 4) NO production was
compare with control group before operation and increased during two days
after operation. One patient in this group had postoperative infection. In the
group D (n = 4) NO production significantly exceed control data before
operation (differ by a factor 2.77, p = 0.00(38) and decreased directly after
operation (p < 0.01); NO production increased at 7 day after operation (p
< 0.01). Infectious complications in group were in 2 cases.
Condusions: Study ofhuman neutrophil function and nitric oxide produc-
tion may be used for prognosis of probable pro- and anti-inflammatory
response of cardiosurgery patients. Exceeding level of nitric oxide before
operation is possible early marker of anti-inflammatory reaction after
operation.
IWeP329I Seroprevalence of toxoplasma antibodies in type II
diabetes mellitus patients
M. Hokelek, H. Kahraman, Y. Uyar, C. Eroglu, S. G. Havuz, M. Sunbul
Ondokuz Mayis University Medical School, Samsun, T"rkey
Objectives: Toxoplasma gondii, well known as an opportunist microorgan-
ism. and obligate intracellular protozoan. is recognized as a major cause of
neurologic morbidity and mortality among immunocompromised patients.
The majority of Type II diabetes mellitus (DM) patients are known to
develop secondary immunodeficiency. The degree of immune alterations
varies with the disease duration. Seroprevalence of T. gondii was investigated
in Type II DM patients in this study.
Methods: Fifty-six Type II DM patients and 46 healthy persons were
included in the study. The patients were selected from the followed-up
patients of Clinic of Endocrinology, Ondokuz Mayis University Hospital.
Sera were stored at -70°C until the assay. T. gondii IgG and IgM specific
a~bodies were measured by using Enzyme Linked Immunosorbent Assay
~). Statistical analysis was performed by using Chi-square test.
Results: Of 56 Type II Diabetic patients IgG was found to be higher than
cut-offvalue in 41 (73.2%) and IgM in 1 (1.8%). As for the control group
IgG was found to be higher than cut-offin 19 (41.3%) and IgM in 1 (2.8%).
IgG seropositivity in DM group was found more significant than healthy
control group as statistically (p < 0.01).
Conclusion: It is suggested that latent toxoplasmosis should be taken into
account in diabetic patients, of which immune system might be disordered.
IWeP330I Parasitic diseases in immunocompromised hosts
without HIV infection
L. G. Popa l.2, C. Cretu l .2, S. Radulescu l •2 , S. Ifrim2, M. Vasile2, V.
Enel .2, M.l. Popal , A. Miliai3
University ofMedicine, Dept. ofMicrobiology, Bucharest, Romania
0bjedIves: Patients whose immune systems are weakened due to various
malignancies, cytotoxic drugs used to treat malignant diseases, cytotoxic
effects of radiation, prolonged corticosteroid therapy could be more readily
become infected with certain parasites. In order to establish this correlation
"'e have made a study in the "N. Gh. Lupu" Hospital of Bucharest.
Methods: The study was realized betweenJanuary-December 1999 enrol-
ling 22 cases (patients with immunosuppression) and 66 immunocompetent
controls, the majority being adults. All the patients were followed-up by
clinical, imagistic and immunological (antibody ELISA detection) methods.
Results: Ten of the 22 patients with immunosupression (44.45%) were
diagnosed with neoplasm, 6 patients had autoimmune diseases and 6 patients
had other causes ofimmunosuppression; 59.09% were males, 54.54% living
in urban areas. Four patients were diagnosed with associated parasitic
infections (toxoplasmosis and toxocariasis).
The parasitic diseases were distributed as follow: toxoplasmosis in 17 cases
(8 ocular, 8 ganglionar and 1cerebral form), toxocariasis in 7 cases (6 Visceral
Larva Migrans and locular form) disseminated multivisceral echinococcosis
in 2 cases. Nine patients presented eosinophilia (7-54%), highest values
being detected in toxocariasis cases. In the immunocompetent patients the
parasitic diseases were significantly reduced.
Patients with toxocariasis and echinococcosis were treated with albenda-
zoic and those with toxoplasmosis were treated with pyrimethamine and
different macrolides.
Condusions: The general course of the diseases was more prolonged in the
immunosuppressed patients comparing to the immunocompentent controls.
We noticed the reactivation of chronic parasitic diseases at the cases, those
patients being much prone to new parasitic infections.
IWeP331! Mobilization of IgG subclasses in a patient with
Kaposi's sarcoma and T-qualitative immunodefidency
S. Argyropoulos', E. Sioula l , TH. Gounaris1, E. Douka l , CH.
Georgopoulou l , A. Kootsopoulos2, D. Chrysovergi3 , G. Saroglou l
,A' Department of 1ntemal Medicine; 2Department ofPathology; J Department
of Immutlology-Histocompatibility, "Evangelismos" General Hospital, Athens,
Greece
We report an unusual case of Kaposi's sarcoma in a 24-yean old G~k
female, who was hospitalised for erysipelas of the right leg. She gave past
history of multiple streptococcal and staphylococcal skin infections and
recurrent episodes of herpes zoster.
On examination were found: mikrognathia, mikroglossia and ambUlant
of iris. Excisional biopsy of two of the three cherry-colored lesions at the
lower extremities revealed Kaposi's sarcoma at tumor stage.
Laboratory data: haematologic, biochemical and endocrinologic profile
were within normal limits, HIV serology, Western-blot! and PCR HlV-l in
plasma were negative. Absolute number ofCD4+ and CD8+ were 1217
cells/dl and 487. Complement levels and functional studies ofPNM's were
normal. Irnmltnoglobulin~~howed borderline increase oflgM and the levels
of subclasses of IgG wen~ within normal limits. Decreased lymphocyte
proliferation responses were found after stimulation with PHA, PWM and
CD3 mAb and measurement of incorporated 3H-Thymidine. Caryorypic
studies did not reveal any phenotypic abnormalities. Serology for HSV-8 in
plasma and in tissue biopsy samples was negative.
The patient was started on interferon 5xlO" l.U.s.c. three times weekly
for six months for treatment and prevention from KS lesions. A third KS
lesion disappeared with treatment. No new lesions have appeared after 8
months follow up. The levels of IgG subclasses were measured after
treatment and were decreased. Eight months after stopping the treatment
with interferon, the levels oflgG subclasses were still low.
IWeP332I Ocular toxoplasmosis in immunosupressed patients
C. M. Cretu'.2, L. G. pOra'·2, M. Popa l , S. Radulescu l .2, L. F. Ristea l , D.
Tacorian l , P. Mihailescu
I University of Medicine; 2"N. Gh. Lup"" Hospital, Bucharest, Romania
Objective: The purpose of this study is to evaluate the clinical and ther-
apeutic aspects in immunosuppressed patients with ocular toxoplasmosis.
Methods: The srudy was realized berweenJanuary 1997-December 1999
enrolling 140 cases, the majority being adults. All the patients were
followed-up by clinical, imagistic and immunological (antibody ELISA
detection) methods.
Results: Out of 140 patients with ocular toxoplasmosis, 6 acquired the
disease after malignancies (breast or bladder cancer), immwle disorders
(ankylotic spondylitis), or degenerative diseases (multiple sclerosis), being
probably, an old reactivated disease (lgM specific antibodies anti-Toxo-
plasma gondii were negative). The ocular lesions were unilateral (except one)
and had the clinical aspect ofan acute chorioretinitis (4 cases), or optic nerve
involvement (2 cases). The diagnosis was established by clinical examination,
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combined with the detection of specific antibodies anti-Toxoplasma gondii
IgM, IgG, IgA on serum or CSF. The specific therapy was differentiated,
using the triple combination pirymethamine/sulfadoxine/corticosteroids, or
pirymethamine/clarithromycine/corticosteroids and, the double combina-
tion of azithromycine/corticosteroids in patients with malignancies. The
results were very good being necessary 1 to 3 courses of treatment, without
relapses. There were no side effects noticed.
CondU51ons: Pirymethamine remains the first choice treatment in ocular
toxoplasmosis, with a good tolerance and very good eye penetration but, in
cases when the drug is contra-indicated, azithromycine seems to be the
alternative.
IWeP333[ Detection of Cryptosporidium oocysts as an enteric
pathogen in immunocompromised patients
A. Yetkinl , F. Aktas2, D. Arman2
Department ofClinical MicrobiolflY and Infectious Diseases of I Ankara
Trailling ami Research Hospital; Gazi University School ofMedicine, Ankara,
Turkey
[n this study, the detection rate Cryptosporidium as a causative agent in
diarrheic immunosuppressed patients who have either hematologic malig-
nancy or solid tumor, is evaluated. For this purpose, three groups; Group [,
group II, group III were formed which consisted of diarrheic immunosup-
presed patients, nondiarrheic immunosuppresed patients and diarrheic
immunocompetent patients respectively. [mmunoflurescence antibody
method was used for the detection of Cryptosporidium oocysts. A total
number of 96 fecal samples were examined, in which seven of them were
positive for Cryptosporidium oocysts. Cryptosporidium was detected six of34
(17.64%) diarrheic immunosuppresed patients and one of 30 (3.33%)
diarrheic immunocompetent patients and none in nondiarrheic immuno-
suppresed patients. The detection rate ofCryptosporidium as a causative agent
among diarrhic patients (group I, group III) is found insignificant (OR =
6.21, CI = 0.66-145.95) where as among immunsuppresed patients (group
I, group II), it is found statistically significant (p < 0.05). As a conclusion
Cryptosporidium may be a causative agent in diarrheic immunosuppressed
patients other than AIDS.
IWeP334! Urinary tract infections (UTls) in patients
undergoing high dose chemotherapy (HDCh) With auto-PBPC
transplantation
E. Mroz, K. Kuzko, G. Mokracka-Latajka, A. Seniuk, A. Lange
Dept. ofMicrobiology, Medical University, BMT Unit ofK. Dluski, Hospitall
Inst. of Immun. and Exp. Therapy, Wroclaw, Poland
Objectives: The purpose of this study was to determine the frequency
(UTIs) in patients (pts) undergoing HDCh with peripheral blood progenitor
cell transplantation (pBPCn.
Methods: 106 pts were transplanted from 1993 until 1997. Forty-nine pts
suffered from solid tumors (19 females and 30 males) and 57 from hemato-
logical malignancies (27 females and 30 males). 77 pts underwent single, 20
tandem and 9 triple courses ofHDCh with PBPCT. Microbiological check-
up covered the period from -30 until + 30 day after PBPCT. Samples of
middle stream urine were inoculated onto McConkey, blood agar and
Sabouraud agar with using of calibrated loops. Identification of strains was
carried out with using by the ATB System (bioMerieux, France). Significant
UTI was considered when more than 1()()()() CFUIml ofurine was observed.
Pts after HDCh with PBPCT showed profound neutropoenia lasting from
one to two weeks after PBPCT and immunosuppression. All of them were
given nonabsorbable antibiotics.
Results: UTIs were observed in 42 out ofl06 (40%) pts. In 5 cases the UTI
was appear before, in 21 cases after and in 16 cases before and after PBPCT.
UTls were seen more frequently during the first and the second week (in 16
and in 12 pts, respectively) than during the third and fourth week (in 6 and 3
pts, respectively) after PBPCT. UTIs were more frequent in females than in
males (50% vs 32%). Isolated pathogens: E coli, Enterobactniaceae, Gram-
positive bacilli, fungi and others. UTIs were caused by single microorgan-
isms or were polymicrobial.
Conduslons: UTIs were observing mmr1y during the nemropoenic period.
Females were more susceptible than males.
IND03 - SmithKline Beecham: Have we reached the point
of no return? ..
IMo13-11 Clinical failures: The tip of the iceberg?
J. Garau
H05pital Mutua de Terra5sa, University ofBarcelona, Spain
In pneumococcal meningitis, resistance in StreptocoCCU5 pneumoniae compro-
mises clinical outcome. However, the clinical impact ofincreasing resistance
on community-acquired respiratory tract inf«'tions (RTis) is less clear.
Clinical efficacy of antibiotics is related to bacteriological outcome
(Dagan et el. Pediatr Infect Dis] 1998;17:776-782), which is influenced by
the pharmacodynamic activity (potency and pharmacokinetics) ofthe agent
against the infecting pathogen. For example, in S. pneumoniae-related acute
otitis media, the bacteriological failure rate of cefaclor and cefuroxime
increa,e, as the minimum inhibitory concentration (MIC) against the
pathogen increases (Dagan et al. Pediatr Infect Dis J 1998;15:980-985).
Macrolide resistance in S. pneumoniae also results in bacteriological failure
in this model (Dagan et al. Antimicrob Agents Chemother 2000:44:43-50).
Surveillance ofclinical isolates from community-acquired R Tis shows that
there i, a trend towards increasing prevalence ofresistant pathogens, and that
the MICs among't these resistant isolates are increasing for a range ofagents.
Emerging data suggest tibet resistance is compromising the efficacy of
routinely used antibacterial agents, for example, reports of clinical and
bacteriological failure ofmacrolides due to tesistance in S. pneumoniae (Garau
et al. ICMAS, 2000, abstract 7.09), and offluoroquinolones in patients with
community-acquired pneumonia.
The results from a number of published clinical trials appear to suggest
that resistance has not significantly compromised the clinical outcome of
routinely used agents. However, these published studies often exclude from
the analysis patients most likely to be infected with resistant pathogens, or
were conducted prior to the current extent of resistance. Recent retro-
spective analyses and increasing sporadic reports of clinical failure due to
resistance may be more reflective ofthe real situation and show the 'tip ofthe
iceberg'. These reports suggest a need to reassess current empiric therapeutic
recommendations for the treatment of community-acquired R TI suspected
to be of pneumococcal etiology.
[Mo13=2j Steering an appropriate course; Principles to guide
antibiotic choice
O. Cars
Swedish Institutefor I"fectious Disease Control, Solna, Sweden
The prevalence and degree of resistance in common R TI pathogens is, in
general, increasing worldwide. Although the health impact of resistance is
not yet fully understood, it is postulated that once the impact is measurable, it
may be too late to apply interventions to reduce resistance levels and regain
previous quality and cost of care. This raises the question of whether, and
how, we should address resistance now, before patient care is irreversibly
compromised.
The association between antibiotic consumption and the prevalence of
resistance is widely assumed. However, evidence suggests that reduction~
consumption may not be the only, or most effective, way ofreduc~
prevalence of resistance. Mathematical modeling to predict the long-tern.
effects of antibiotic consumption on resistance shows that the timescale for
the emergence ofresistance is typically shorter than the decay time following
a decline in antibiotic consumption. Increasing evidence suggests that
bacteria acquire 'compensatory genes', which reduce the fitness cost of
resistance and, therefore, the benefit of losing resistance mechanisms in the
absence ofantibiotics. Co-selection of multi-resistant bacteria by any agent
to which they are resistant suggests that even if overall consumption of
antibiotics is reduced, continued use of agents that select for co-resistances
could counteract the desired positive effects. Against this background a
general principle is proposed: not only should antibiotics not be used where
unnecessary or inappropriate, bur also, if antibiotic therapy is deemed
necessary, the agent used should be appropriate. The guiding principle for
appropriate prescribing is to maximize patient outcome whilst minimizing
the potential for selection and spread of resistance by using agents with
sufficient pharmacodynamics (potency and pharmacokinetics) to elicit rapid
eradication of the bacterial population, including emerging resistant
mutants, from the infection site. Whilst the choice of agent may not be
the same in all regions and will depend on local resistance trends and disease
aetiology. the application of these principles may help to preserve the
benefits of antibiotic therapy.
